{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:35:36Z","timestamp":1783665336715,"version":"3.55.0"},"reference-count":40,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2024,10,23]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis has been recognised to present with the syndrome of catatonia. In severe cases dysautonomia is representative of malignant catatonia. The treatment with benzodiazepines (BZDs) and electroconvulsive therapy (ECT) may decrease morbidity and mortality in patients presenting with anti-NMDA receptor encephalitis and catatonia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective case series of eight patients with anti-NMDA receptor encephalitis treated with ECT. We use clinical prediction scores (Clinical Assessment Scale for Autoimmune Encephalitis [CASE] and anti-NMDAR Encephalitis One-Year Functional Status scores) to compare expected outcomes and observed outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CASE scores in our group ranged between 5 and 19, with a mean score of 13.8 (median 15.5). NEOS scores ranged from 2 to 4, with a mean and median of 3. Of the eight patients, six had a favourable modified Rankin Score (0\u20132) at a follow-up of 8 to 12 months. Patients received an average of 29.9 ECT treatments in total.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Based on clinical prediction scores, this cohort had better than expected functional outcomes. We discuss the use of BZDs and ECT in these cases and propose a treatment algorithm for patients who present with catatonic syndrome in anti-NMDA receptor encephalitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2024-000812","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:50:13Z","timestamp":1731459013000},"page":"e000812","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Catatonia in anti-NMDA receptor encephalitis: a case series and approach to improve outcomes with electroconvulsive therapy"],"prefix":"10.1136","volume":"6","author":[{"given":"F. Gabriela","family":"Kraiter","sequence":"first","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakota T.","family":"May","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Health, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Slauer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Health, Duke University School of Medicine, Durham, North Carolina, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Abburi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-3972","authenticated-orcid":false,"given":"Christopher","family":"Eckstein","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Komisar","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Health, Duke University School of Medicine, Durham, North Carolina, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-1292","authenticated-orcid":false,"given":"Jacob P.","family":"Feigal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Health, Duke University School of Medicine, Durham, North Carolina, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2025072811205604000_6.2.e000812.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"2025072811205604000_6.2.e000812.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708712"},{"key":"2025072811205604000_6.2.e000812.3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21050"},{"key":"2025072811205604000_6.2.e000812.4","article-title":"The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis","volume":"13","author":"Olaleye","year":"2021","journal-title":"Cureus"},{"key":"2025072811205604000_6.2.e000812.5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chc.2018.07.005","article-title":"Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy: Literature Review and Future Directions","volume":"28","author":"Tanguturi","year":"2019","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"2025072811205604000_6.2.e000812.6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","article-title":"Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: A systematic review of cases","volume":"12","author":"Warren","year":"2019","journal-title":"Brain Stimul"},{"key":"2025072811205604000_6.2.e000812.7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1192\/pb.bp.113.045518","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment","volume":"39","author":"Barry","year":"2015","journal-title":"BJPsych Bull"},{"key":"2025072811205604000_6.2.e000812.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70222-X"},{"key":"2025072811205604000_6.2.e000812.9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.9740\/mhc.2016.11.297","article-title":"Anti-NMDA receptor encephalitis: An emerging differential diagnosis in the psychiatric community","volume":"6","author":"Nichols","year":"2016","journal-title":"Ment Health Clin"},{"key":"2025072811205604000_6.2.e000812.10","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.2174\/0929867325666180221142623","article-title":"Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker","volume":"27","author":"Wang","year":"2020","journal-title":"Curr Med Chem"},{"key":"2025072811205604000_6.2.e000812.11","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.638901","article-title":"Developing Consensus in the Assessment and Treatment Pathways for Autoimmune Encephalitis in Child and Adolescent Psychiatry","volume":"12","author":"Mooneyham","year":"2021","journal-title":"Front Psychiatry"},{"key":"2025072811205604000_6.2.e000812.12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.21.4.371"},{"key":"2025072811205604000_6.2.e000812.13","doi-asserted-by":"crossref","first-page":"796965","DOI":"10.3389\/fimmu.2021.796965","article-title":"Validation of the Clinical Assessment Scale in Autoimmune Encephalitis in Chinese Patients","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"2025072811205604000_6.2.e000812.14","doi-asserted-by":"crossref","first-page":"915352","DOI":"10.3389\/fimmu.2022.915352","article-title":"Performance of the clinical assessment scale for autoimmune encephalitis in a pediatric autoimmune encephalitis cohort","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"2025072811205604000_6.2.e000812.15","first-page":"e244","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology (ECronicon)"},{"key":"2025072811205604000_6.2.e000812.16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"2025072811205604000_6.2.e000812.17","doi-asserted-by":"publisher","DOI":"10.1177\/08850666221114303"},{"key":"2025072811205604000_6.2.e000812.18","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1176\/appi.neuropsych.15080211","article-title":"A Case of Neuropsychiatric Lupus With Severe Malignant Catatonia that Improved With Daily Electroconvulsive Therapy","volume":"28","author":"Jones","year":"2016","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2025072811205604000_6.2.e000812.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2034954"},{"key":"2025072811205604000_6.2.e000812.20","doi-asserted-by":"crossref","unstructured":"Louie AT-H , Anand E , Baldwin I , et al . Use of En-Bloc Multiple Monitored Electroconvulsive Therapy in Benzodiazepine Refractory Malignant Catatonia. J ECT 2024. doi:10.1097\/YCT.0000000000001020","DOI":"10.1097\/YCT.0000000000001020"},{"key":"2025072811205604000_6.2.e000812.21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/cap.2016.0180","article-title":"Neuroleptic Malignant Syndrome\/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series","volume":"27","author":"Ghaziuddin","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2025072811205604000_6.2.e000812.22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YCT.0000000000000600","article-title":"Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A Case Series","volume":"35","author":"Morcos","year":"2019","journal-title":"J ECT"},{"key":"2025072811205604000_6.2.e000812.23","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0b013e3181c18a13"},{"key":"2025072811205604000_6.2.e000812.24","doi-asserted-by":"publisher","DOI":"10.1097\/00124509-200006000-00002"},{"key":"2025072811205604000_6.2.e000812.25","unstructured":"Therapy APACoE . The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association. 2nd edn. Washington, DC: American Psychiatric Association Publishing, 2001."},{"key":"2025072811205604000_6.2.e000812.26","article-title":"Malignant Catatonia Warrants Early Psychiatric-Critical Care Collaborative Management: Two Cases and Literature Review","volume":"2017","author":"Park","year":"2017","journal-title":"Case Rep Crit Care"},{"key":"2025072811205604000_6.2.e000812.27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/pcn.12867","article-title":"Catatonia in patients with anti-NMDA receptor encephalitis","volume":"73","author":"Espinola-Nadurille","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"2025072811205604000_6.2.e000812.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00378-2"},{"key":"2025072811205604000_6.2.e000812.29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamapsychiatry.2023.0728","article-title":"Understanding the Mechanisms of Action of Electroconvulsive Therapy: Revisiting Neuroinflammatory and Neuroplasticity Hypotheses","volume":"80","author":"Cano","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2025072811205604000_6.2.e000812.30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpsychires.2022.03.061","article-title":"Immunological changes following electroconvulsive therapy in multiple sclerosis","volume":"150","author":"Kavakbasi","year":"2022","journal-title":"J Psychiatr Res"},{"key":"2025072811205604000_6.2.e000812.31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.seizure.2015.12.015","article-title":"Electroconvulsive therapy for refractory status epilepticus: A systematic review","volume":"35","author":"Zeiler","year":"2016","journal-title":"Seizure"},{"key":"2025072811205604000_6.2.e000812.32","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.646466","article-title":"ECT in an Adolescent With Schizophrenia and Seizures: Case Report","volume":"12","author":"Gralewicz","year":"2021","journal-title":"Front Psychiatry"},{"key":"2025072811205604000_6.2.e000812.33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.yebeh.2006.06.013","article-title":"Electroconvulsive therapy in patients with epilepsy","volume":"9","author":"Lunde","year":"2006","journal-title":"Epilepsy Behav"},{"key":"2025072811205604000_6.2.e000812.34","doi-asserted-by":"crossref","unstructured":"Gistelinck L , Van de Velde N , Tandt H , et al . Effectiveness and Safety of Flumazenil Augmentation During Electroconvulsive Therapy. J ECT 2024. doi:10.1097\/YCT.0000000000001003","DOI":"10.1097\/YCT.0000000000001003"},{"key":"2025072811205604000_6.2.e000812.35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301180"},{"key":"2025072811205604000_6.2.e000812.36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300411"},{"key":"2025072811205604000_6.2.e000812.37","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1097\/YCT.0000000000000907","article-title":"Electroconvulsive Therapy Restores Higher-Level Cognition in Catatonia","volume":"39","author":"Amad","year":"2023","journal-title":"J ECT"},{"key":"2025072811205604000_6.2.e000812.38","doi-asserted-by":"crossref","first-page":"578369","DOI":"10.1016\/j.jneuroim.2024.578369","article-title":"Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature","volume":"392","author":"Wright","year":"2024","journal-title":"J Neuroimmunol"},{"key":"2025072811205604000_6.2.e000812.39","first-page":"578404","article-title":"Correspondence: Electroconvulsive therapy in N-methyl-D-aspartate receptor encephalitis","volume":"2024","author":"Komisar","year":"2024","journal-title":"J Neuroimmunol"},{"key":"2025072811205604000_6.2.e000812.40","doi-asserted-by":"crossref","first-page":"578271","DOI":"10.1016\/j.jneuroim.2023.578271","article-title":"Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series","volume":"386","author":"Wadi","year":"2024","journal-title":"J Neuroimmunol"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2024-000812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:21:07Z","timestamp":1753726867000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2024-000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bmjno-2024-000812"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2024-000812","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}